{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:21:54Z","timestamp":1773098514373,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"funder":[{"name":"Sbarro Health Research Organization (http:\/\/www.shro.org)"},{"DOI":"10.13039\/501100003823","name":"Human Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003823","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Commonwealth of Pennsylvania"},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2014-15690"],"award-info":[{"award-number":["IG 2014-15690"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cell. Physiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1002\/jcp.25397","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T21:43:07Z","timestamp":1459633387000},"page":"129-135","source":"Crossref","is-referenced-by-count":17,"title":["SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration"],"prefix":"10.1002","volume":"232","author":[{"given":"Paola","family":"Indovina","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgery and Neuroscience; University of Siena and Istituto Toscano Tumori (ITT); Siena Italy"},{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology; Temple University; Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Casini","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neuroscience; University of Siena and Istituto Toscano Tumori (ITT); Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris Maria","family":"Forte","sequence":"additional","affiliation":[{"name":"Oncology Research Center of Mercogliano (CROM); Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d-IRCCS; Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Garofano","sequence":"additional","affiliation":[{"name":"AORN Dei Colli Monaldi UOC, Oncology; Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Cesari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neuroscience; University of Siena and Istituto Toscano Tumori (ITT); Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelina Antonella","family":"Iannuzzi","sequence":"additional","affiliation":[{"name":"Oncology Research Center of Mercogliano (CROM); Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d-IRCCS; Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Del Porro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neuroscience; University of Siena and Istituto Toscano Tumori (ITT); Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pentimalli","sequence":"additional","affiliation":[{"name":"Oncology Research Center of Mercogliano (CROM); Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d-IRCCS; Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Napoliello","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neuroscience; University of Siena and Istituto Toscano Tumori (ITT); Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Boffo","sequence":"additional","affiliation":[{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology; Temple University; Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Schenone","sequence":"additional","affiliation":[{"name":"Pharmacy Department; University of Genoa; Genoa Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Botta","sequence":"additional","affiliation":[{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology; Temple University; Philadelphia, Pennsylvania"},{"name":"Department of Biotechnology, Chemistry and Pharmacy; University of Siena; Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology; Temple University; Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"10.1002\/jcp.25397-BIB0001|jcp25397-cit-0001","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2353\/ajpath.2007.060971","article-title":"Inhibition of notch signaling induces neural differentiation in Ewing sarcoma","volume":"170","author":"Baliko","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1002\/jcp.25397-BIB0002|jcp25397-cit-0002","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1158\/0008-5472.CAN-07-6145","article-title":"EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma","volume":"68","author":"Ban","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.25397-BIB0003|jcp25397-cit-0003","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1158\/0008-5472.CAN-14-1736","article-title":"Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma","volume":"74","author":"Ban","year":"2014","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.25397-BIB0004|jcp25397-cit-0004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1634\/theoncologist.11-5-503","article-title":"Ewing's sarcoma family of tumors: Current management","volume":"11","author":"Bernstein","year":"2006","journal-title":"Oncologist"},{"key":"10.1002\/jcp.25397-BIB0005|jcp25397-cit-0005","doi-asserted-by":"crossref","first-page":"e1004475","DOI":"10.1371\/journal.pgen.1004475","article-title":"The genomic landscape of the Ewing sarcoma family of tumors reveals recurrent STAG2 mutation","volume":"10","author":"Brohl","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1002\/jcp.25397-BIB0006|jcp25397-cit-0006","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/jm050603r","article-title":"Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation","volume":"49","author":"Carraro","year":"2006","journal-title":"J Med Chem"},{"key":"10.1002\/jcp.25397-BIB0007|jcp25397-cit-0007","doi-asserted-by":"crossref","first-page":"12421","DOI":"10.18632\/oncotarget.3043","article-title":"SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation","volume":"6","author":"Casini","year":"2015","journal-title":"Oncotarget"},{"key":"10.1002\/jcp.25397-BIB0008|jcp25397-cit-0008","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jcb.25042","article-title":"SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment","volume":"116","author":"Ceccherini","year":"2015","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcp.25397-BIB0009|jcp25397-cit-0009","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4161\/cc.11.5.19519","article-title":"Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition","volume":"11","author":"Cozzi","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1002\/jcp.25397-BIB0010|jcp25397-cit-0010","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","article-title":"The genomic landscape of pediatric Ewing sarcoma","volume":"4","author":"Crompton","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1002\/jcp.25397-BIB0011|jcp25397-cit-0011","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.emboj.7601085","article-title":"Src kinase phosphorylates Caspase-8 on Tyr380: A novel mechanism of apoptosis suppression","volume":"25","author":"Cursi","year":"2006","journal-title":"EMBO J"},{"key":"10.1002\/jcp.25397-BIB0012|jcp25397-cit-0012","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jnci\/djq278","article-title":"Long-term survivors of childhood Ewing sarcoma: Report from the childhood cancer survivor study","volume":"102","author":"Ginsberg","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/jcp.25397-BIB0013|jcp25397-cit-0013","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1200\/JCO.2008.19.1478","article-title":"Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study","volume":"27","author":"Granowetter","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcp.25397-BIB0014|jcp25397-cit-0014","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/jcp.25397-BIB0015|jcp25397-cit-0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1535-7163.MCT-08-0058","article-title":"Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma","volume":"7","author":"Guan","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jcp.25397-BIB0016|jcp25397-cit-0016","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/onc.2011.286","article-title":"New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization","volume":"31","author":"Indovina","year":"2012","journal-title":"Oncogene"},{"key":"10.1002\/jcp.25397-BIB0017|jcp25397-cit-0017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jcp.24170","article-title":"Emerging roles of RB family: New defense mechanisms against tumor progression","volume":"228","author":"Indovina","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1002\/jcp.25397-BIB0018|jcp25397-cit-0018","doi-asserted-by":"crossref","first-page":"17873","DOI":"10.18632\/oncotarget.4286","article-title":"RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy","volume":"6","author":"Indovina","year":"2015","journal-title":"Oncotarget"},{"key":"10.1002\/jcp.25397-BIB0019|jcp25397-cit-0019","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1038\/sj.onc.1202835","article-title":"Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors","volume":"18","author":"Karni","year":"1999","journal-title":"Oncogene"},{"key":"10.1002\/jcp.25397-BIB0020|jcp25397-cit-0020","doi-asserted-by":"crossref","first-page":"e5415","DOI":"10.1371\/journal.pone.0005415","article-title":"A molecular function map of Ewing's sarcoma","volume":"4","author":"Kauer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1002\/jcp.25397-BIB0021|jcp25397-cit-0021","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1074\/jbc.M607630200","article-title":"Notch signaling suppresses p38 MAPK activity via induction of MKP-1 in myogenesis","volume":"282","author":"Kondoh","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25397-BIB0022|jcp25397-cit-0022","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/gm129","article-title":"Downstream EWS\/FLI1-Upstream Ewing's sarcoma","volume":"2","author":"Kovar","year":"2010","journal-title":"Genome Med"},{"key":"10.1002\/jcp.25397-BIB0023|jcp25397-cit-0023","doi-asserted-by":"crossref","first-page":"30383","DOI":"10.1074\/jbc.M606412200","article-title":"Perlecan proteolysis induce san alpha2beta1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation","volume":"281","author":"Laplante","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25397-BIB0024|jcp25397-cit-0024","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.abb.2007.06.004","article-title":"Suppression of c-Src activity stimulates muscle differentiation via p38 MAPK activation","volume":"465","author":"Lim","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1002\/jcp.25397-BIB0025|jcp25397-cit-0025","doi-asserted-by":"crossref","first-page":"e33414","DOI":"10.1371\/journal.pone.0033414","article-title":"The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1002\/jcp.25397-BIB0026|jcp25397-cit-0026","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1158\/1078-0432.CCR-04-2050","article-title":"P38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death","volume":"11","author":"Myatt","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcp.25397-BIB0027|jcp25397-cit-0027","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.onc.1210705","article-title":"The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity","volume":"27","author":"Myatt","year":"2008","journal-title":"Oncogene"},{"key":"10.1002\/jcp.25397-BIB0028|jcp25397-cit-0028","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1158\/0008-5472.CAN-08-4041","article-title":"Advances in Ewing's sarcoma research: Where are we now and what lies ahead","volume":"69","author":"Ord\u00f3\u00f1ez","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.25397-BIB0029|jcp25397-cit-0029","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdp155","article-title":"Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Paulussen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1002\/jcp.25397-BIB0030|jcp25397-cit-0030","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1021\/jm400233w","article-title":"Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant","volume":"56","author":"Radi","year":"2013","journal-title":"J Med Chem"},{"key":"10.1002\/jcp.25397-BIB0031|jcp25397-cit-0031","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/cdd.2011.171","article-title":"Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo","volume":"19","author":"Raimondi","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1002\/jcp.25397-BIB0032|jcp25397-cit-0032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1741-7015-10-141","article-title":"Notch signaling in pediatric soft tissue sarcomas","volume":"10","author":"Rota","year":"2012","journal-title":"BMC Med"},{"key":"10.1002\/jcp.25397-BIB0033|jcp25397-cit-0033","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.bmcl.2004.03.013","article-title":"New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation","volume":"14","author":"Schenone","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1002\/jcp.25397-BIB0034|jcp25397-cit-0034","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/13543784.2010.499898","article-title":"Novel dual Src\/Abl inhibitors for hematologic and solid malignancies","volume":"19","author":"Schenone","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1002\/jcp.25397-BIB0035|jcp25397-cit-0035","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-06-3469","article-title":"Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival","volume":"67","author":"Shor","year":"2007","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.25397-BIB0036|jcp25397-cit-0036","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1096\/fj.07-9873com","article-title":"Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells","volume":"22","author":"Spreafico","year":"2008","journal-title":"FASEB J"},{"key":"10.1002\/jcp.25397-BIB0037|jcp25397-cit-0037","first-page":"353","article-title":"In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines","volume":"19","author":"Timeus","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1002\/jcp.25397-BIB0038|jcp25397-cit-0038","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","article-title":"Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations","volume":"4","author":"Tirode","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1002\/jcp.25397-BIB0039|jcp25397-cit-0039","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.463","article-title":"CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-\u03baB signaling","author":"Ventura","year":"2015","journal-title":"Oncogene"},{"key":"10.1002\/jcp.25397-BIB0040|jcp25397-cit-0040","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/sj.bjc.6605896","article-title":"Fenretinide-dependent upregulation of death receptors through ASK1 and p38\u03b1 enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours","volume":"103","author":"White","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1002\/jcp.25397-BIB0041|jcp25397-cit-0041","doi-asserted-by":"crossref","first-page":"47912","DOI":"10.1074\/jbc.M409035200","article-title":"Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38MAPK and up-regulation of the death receptor p75NTR","volume":"279","author":"Williamson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25397-BIB0042|jcp25397-cit-0042","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1200\/JCO.2011.41.5703","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group","volume":"30","author":"Womer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcp.25397-BIB0043|jcp25397-cit-0043","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mc.20716","article-title":"Fyn is induced by Ras\/PI3K\/Akt signaling and is required for enhanced invasion\/migration","volume":"50","author":"Yadav","year":"2011","journal-title":"Mol Carcinog"},{"key":"10.1002\/jcp.25397-BIB0044|jcp25397-cit-0044","doi-asserted-by":"crossref","first-page":"19112","DOI":"10.1074\/jbc.M709882200","article-title":"SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis","volume":"283","author":"Yamaguchi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25397-BIB0045|jcp25397-cit-0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc1366","article-title":"A reinassance for SRC","volume":"4","author":"Yeatman","year":"2004","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Cellular Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcp.25397","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcp.25397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T12:02:42Z","timestamp":1625313762000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcp.25397"}},"subtitle":["SFK INHIBITION IN EWING SARCOMA CELLS"],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jcp.25397","archive":["Portico"],"relation":{},"ISSN":["0021-9541"],"issn-type":[{"value":"0021-9541","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}